Global Point Of Care
Global Point Of Care
~1 de cada 3 pacientes que mueren en el hospital tiene sepsis1
Principal coste de hospitalización en hospitales de EE. UU., con un total
> 27 000 millones de dólares al año2
Causa principal de mortalidad hospitalaria en EE. UU., hasta un 70 % en pacientes con choque séptico3,4
Un paquete de medidas asistenciales actualizado y basado en pruebas de Surviving Sepsis Campaign (SSC), lanzada en 2018, enfatiza la oportunidad de la atención para mejorar la supervivencia.
Paquete de medidas asistenciales hora-1 de SSC 2018 |
Medir el nivel de lactato. Volver a medir si el lactato inicial es >2 mmol/l. |
Obtener hemocultivos antes de la administración de antibióticos. |
Administrar antibióticos de amplio espectro. |
Administrar rápidamente 30 ml/kg de cristaloides para la hipotensión o lactato ≥4 mmol/l |
Aplicar vasopresores si el paciente está hipotenso durante la reanimación con líquidos para mantener la PAM ≥65 mmHg. |
Cuando cada minuto cuenta, i-STAT CG4+ mejora la eficiencia, la coordinación y la comunicación del equipo de atención, y dirige rápidamente los recursos a quienes más lo necesitan.
1. CDC Sepsis Fact Sheet.
2. What is Sepsis? Infographic. Sepsis Alliance. www.sepsis.org
3. Sepsis Alliance Sepsis Fact Sheet.
4. Advisory Board Sepsis Research Report.
5. Levy MM, Evans LE, Rhodes A.
6. Singer AJ, Taylor M, LeBlanc D et al. 2014.
7. Singer AJ, Taylor M, LeBlanc D et al. 2018.
8. Ward MJ, Self WH, Singer A et al.
9. Kumar et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. June 2006. https://www.ncbi.nlm.nih.gov/pubmed/16625125
A Leader In Rapid Point-OF-CARE DIAGNOSTICS.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement | Declaration for California Compliance Law.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.